A novel bioengineered fragment peptide of Vasostatin-1 exerts smooth muscle pharmacological activities and anti-angiogenic effects via blocking VEGFR signalling pathway

Publication date: Available online 3 May 2021Source: Computational and Structural Biotechnology JournalAuthor(s): Ran Wei, Qiushuang Wu, Nana Ai, Lei Wang, Mei Zhou, Chris Shaw, Tianbao Chen, Richard Dequan Ye, Wei Ge, Shirley W.I. Siu, Hang Fai Kwok

Source: Computational and Structural Biotechnology Journal - May 4, 2021 Category: Biotechnology Source Type: research